All Press Releases
IndoSec 2024 shaping up to be a Battleground for Giants
ACN Newswire
•
Jun 06, 2024 15:50 HKT/SGT
JAKARTA, June 5, 2024 - (ACN Newswire) - Indonesia's own cybersecurity saga, aka IndoSec, an annual event with the reputation of convening the industry's top leaders is now gearing up for its 7th edition. Scheduled to take place on 24 – 25 September 2024 at the Jakarta Convention C
The 11th PropertyGuru Asia Property Awards (Mainland China, Hong Kong, Macau) are now accepting entries across new, diverse categories
PropertyGuru Group
•
Jun 06, 2024 11:52 HKT/SGT
HONG KONG, June 6, 2024 - (ACN Newswire) - Organisers of the PropertyGuru Asia Property Awards (Mainland China, Hong Kong, Macau) have announced an expanded roster of categories for the programme's 2024 edition. The 11th PropertyGuru Asia Property Awards (Mainland China, Hong Kong, Macau
GMG's THERMAL-XR(R) Energy Savings Coating Wins Industry Product Excellence Award
Graphene Manufacturing Group Ltd
•
Jun 05, 2024 20:09 HKT/SGT
Brisbane, Queensland, Australia--(ACN Newswire - June 5, 2024) - Graphene Manufacturing Group Ltd. (TSXV: GMG) ("GMG" or the "Company") is pleased to provide a business update on the commercialisation progress of THERMAL-XR® Powered by GMG Graphene. Image 1To view an enhanced version of this gr
3rd Clean Power & New Energy 2024; Take a Deep Dive into the Latest Transition of Renewable Energies
ACN Newswire
•
Jun 05, 2024 15:31 HKT/SGT
KUALA LUMPUR, June 5, 2024 - (ACN Newswire) - Join an impressive line-up of experts, all geared up to share profound knowledge and expertise on achieving net zero emissions, the fast tracking of energy transition, and the latest advancements and opportunities in renewable energy. Themed "TRIP
Startup ecosystem in Southeast Asia and India show signs of maturity - Profitability and customer-centricity take centre stage: HubSpot Study
HubSpot
•
Jun 05, 2024 15:00 HKT/SGT
SINGAPORE, June 5, 2024 - (ACN Newswire) - HubSpot, the customer platform for scaling businesses, today announced the findings of a study conducted by Milieu Insight that explored the trends and innovations shaping the startup landscape in Southeast Asia and India. Despite current global economic h
Pride for All: Thailand Celebrates and Empowers Equality and Gender Diversity for Pride Month 2024
Central Pattana PCL
•
Jun 05, 2024 14:00 HKT/SGT
BANGKOK, June 4, 2024 - (ACN Newswire) - Central Pattana proudly launches 'Pride for All,' a nationwide campaign celebrating Pride Month at Central shopping centers. Aligning with recent government policies advocating for diversity and equality, this initiative aims to position Thailand as a top LGB
Advancing Customer Experience Solutions at World CX Summit and Awards
ACN Newswire
•
Jun 05, 2024 13:40 HKT/SGT
MUMBAI, INDIA, June 3, 2024 - (ACN Newswire) - The 11th global edition of the World CX Summit and Awards, an event by Trescon, drew to a close at the Leela, Mumbai on 22nd May 2024. The event was attended by over 200+ CX experts participating in a day filled with insightful discussions focusing on s
Kucingko Inks Underwriting Agreement with Kenanga Investment Bank
Kenanga Investment Bank Bhd
•
Jun 05, 2024 13:00 HKT/SGT
KUALA LUMPUR, June 5, 2024 - (ACN Newswire) - Kucingko Berhad ("Kucingko" or the "Company"), an established 2D animation production services provider, is pleased to announce the signing of an underwriting agreement with Kenanga Investment Bank Berhad ("Kenanga Investmen
Fintech360 and TradingView Enter into Partnership for Innovation and Efficiency
ACN Newswire
•
Jun 05, 2024 12:00 HKT/SGT
NEW YORK, June 4, 2024 - (ACN Newswire) - Recently, Fintech360 has proudly announced that they enter into partnership with TradingView. The forex brokerage industry is rapidly evolving, and Fintech360 stands at the forefront, driving innovation and efficiency. A pivotal factor in this success i
君聖泰醫藥將在2024年國際肝病大會發布MASH臨床2a期研究分析結果，進一步展現熊去氧膽小檁鹼（HTD1801）的療效與安全性
HighTide Therapeutics Inc.
•
Jun 05, 2024 09:00 HKT/SGT
中國深圳、美國馬里蘭州羅克維爾, 2024年6月5日 - (亞太商訊) - 君聖泰醫藥（股票代碼: 2511.HK），一家專注於慢性肝病和代謝性疾病多靶點創新療法的醫藥公司，宣布將於歐洲肝臟研究協會（EASL）2024年大會（6月5日-8日，意大利米蘭）上發表多項研究成果，包括熊去氧膽小檗鹼（HTD1801）作為對靶向腸-肝系統的抗炎及代謝調節劑，在代謝異常性脂肪性肝炎（MASH）合併2型糖尿病（T2DM）患者中的臨床2a期研究事後分析結果（NCT03656744）。 君聖泰醫藥的首席開發官Leigh MacConell博士表示：「HTD1801是一個多靶點新分子實體，正在開展針對
君圣泰医药将在2024年国际肝病大会发布MASH临床2a期研究分析结果，进一步展现熊去氧胆小檗碱（HTD1801）的疗效与安全性
HighTide Therapeutics Inc.
•
Jun 05, 2024 09:00 HKT/SGT
中国深圳、美国马里兰州罗克维尔, 2024年6月5日 - (亚太商讯) - 君圣泰医药（股票代码: 2511.HK），一家专注于慢性肝病和代谢性疾病多靶点创新疗法的医药公司，宣布将于欧洲肝脏研究协会（EASL）2024年大会（6月5日-8日，意大利米兰）上发表多项研究成果，包括熊去氧胆小檗碱（HTD1801）作为对靶向肠-肝系统的抗炎及代谢调节剂，在代谢异常性脂肪性肝炎（MASH）合并2型糖尿病（T2DM）患者中的临床2a期研究事后分析结果（NCT03656744）。 君圣泰医药的首席开发官Leigh MacConell博士表示："HTD1801是一个多靶点新分子实体，
HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate (HTD1801)
HighTide Therapeutics Inc.
•
Jun 05, 2024 09:00 HKT/SGT
ROCKVILLE, MD and SHENZHEN, CHINA, June 5, 2024 - (ACN Newswire) - HighTide Therapeutics, Inc. (HKEX: 2511), a clinical stage biopharmaceutical company specializing in the development of multi-targeted therapies for chronic liver and metabolic diseases, announced that it will make multiple presentat
Rover Announces Intent to Pursue Strategic Alternatives for Its Cabin Gold Project
Rover Critical Minerals Corp
•
Jun 05, 2024 07:00 HKT/SGT
Vancouver, BC, June 5, 2024 - (ACN Newswire) - Rover Critical Minerals Corp. (TSXV:ROVR)(OTCQB:ROVMF)(FSE:4XO) ("Rover" or the "Company") is pleased to announce the completion of a NI 43-101 Technical Report for its 100% owned Cabin Gold project (the "Cabin Technical Report"), NT, Canada. The Compa
BIO24에서 발표된 새로운 연구에서 내부 규제 사항을 갖춘 CRO는 생명공학 기업에게 30%의 절감을 제공하고, 시간을 절반으로 줄이며, 위험을 줄입니다
ACN Newswire
•
Jun 04, 2024 22:56 HKT/SGT
웨이크 포레스트, 노스캐롤라이나 | 호주 애들레이드, 2024년 6월 4일 - (ACN Newswire) - 수상 경력을 가진 호주 및 북미 시장을 선도하는 생명공학용 CRO인 Avance Clinical 은 BIO 2024에서 Frost & Sullivan 연구로부터 새로운 데이터를 공유하고 있습니다. 이 연구는 내부 과학 및 규제 업무를 보유한 CRO와 협력할 때 생명공학 기업이 비용을 30% 이상 절감하고 시동 시간을 절반으로 줄인다는 것을 보여줍니다. BIO 2024 부스 #5601에서 당사 팀과 만나보세
新研究發現，具有內部監管事務的CRO公司為生物技術公司節省30%的成本，縮短時間線一半，降低風險
ACN Newswire
•
Jun 04, 2024 22:46 HKT/SGT
北卡羅來納州威克森林| 澳洲阿德萊德, 2024年6月4日- (亞太商訊) - Avance Clinical, 作為澳大利亞和北美市場領先的獲獎生物技術CRO公司，正在與Frost & Sullivan研究共享新的數據，該數據顯示與具有內部科學和監管事務的CRO公司合作，生物技術公司可以節省超過30%的成本，並將啟動時間縮短一半。 在BIO 2024展位＃5601見我們的團隊 https://www.avancecro.com/events/meet-us-at-bio-international-in-san-diego/#book-a-meeting 在這裡下載報
新研究发现，具有内部监管事务的CRO公司为生物技术公司节省30%的成本，缩短时间线一半，降低风险
ACN Newswire
•
Jun 04, 2024 22:25 HKT/SGT
北卡罗来纳州威克森林 | 澳大利亚阿德莱德, 2024年6月4日 - (亚太商讯) - Avance Clinical, 作为澳大利亚和北美市场领先的获奖生物技术CRO公司，正在与Frost & Sullivan研究共享新的数据，该数据显示与具有内部科学和监管事务的CRO公司合作，生物技术公司可以节省超过30%的成本，并将启动时间缩短一半。 在BIO 2024展位＃5601见我们的团队 在这里下载报告: [报告链接] 根据报告，与具有内部科学和监管事务的CRO公司合作对生物技术公司的主要好处包括： 通过协助赞助商准备研究方案、审核必要文件并为试验点准备激活，将试验
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for Biotechs
ACN Newswire
•
Jun 04, 2024 22:00 HKT/SGT
BIO 2024 - SAN DIEGO, CA, June 4, 2024 - (ACN Newswire) - Avance Clinical, the market-leading Australian & North American CRO for biotechs, will share new research at BIO 2024 from Frost & Sullivan showing that biotechs can save more than 30% in costs, halve start-up times, and cu
[MEDIA ALERT] Fast Food Era - Is This The Demise of A Good Digestive Health?
ACN Newswire
•
Jun 04, 2024 20:15 HKT/SGT
SINGAPORE, June 3, 2024 - (ACN Newswire) - The fast-paced lifestyle of Singaporeans has led many to turn to fast food as a convenient dining choice. According to a 2018 Nielsen survey, it is revealed that 76% of Singaporeans choose fast food outlets for a speedy meal. In addition, about 55
![[MEDIA ALERT] Fast Food Era - Is This The Demise of A Good Digestive Health?](https://photos.acnnewswire.com/20240603_LAC.jpg)
香港摩天轮现任营运商The Entertainment Corporation Limited成功再获标案
ACN Newswire
•
Jun 04, 2024 17:26 HKT/SGT
香港, 2024年6月4日 - (亚太商讯) - 香港摩天轮现任营运商The Entertainment Corporation Limited(「TECL」)荣幸宣布再次成功获得标案，将在未来五年继续营运这标志性景点，体现TECL致力为本地及海外客带来独特及大众化体验。 自2017年以来，香港摩天轮在TECL的管理及友邦保险的冠名赞助下已接待超过 800万人次。 TECL表示，香港摩天轮的票价将在新营运任期内维持于超值价格 ─ 每程20港元，与众同乐。 TECL首席执行官Randy Bloom表示：「香港摩天轮已成为香港天际线具代表性的景点之一，我们很荣幸能继续营运香
香港摩天輪現任營運商The Entertainment Corporation Limited成功再獲標案
ACN Newswire
•
Jun 04, 2024 17:19 HKT/SGT
香港, 2024年6月4日 - (亞太商訊) - 香港摩天輪現任營運商The Entertainment Corporation Limited(「TECL」)榮幸宣佈再次成功獲得標案，將在未來五年繼續營運這標誌性景點，體現TECL致力為本地及海外客帶來獨特及大眾化體驗。 自2017年以來，香港摩天輪在TECL的管理及友邦保險的冠名贊助下已接待超過 800萬人次。 TECL表示，香港摩天輪的票價將在新營運任期內維持於超值價格 ─ 每程20港元，與眾同樂。 TECL首席執行官Randy Bloom表示：「香港摩天輪已成為香港天際線具代表性的景點之一，我們很榮幸能繼續營運香